Risk of gastric cancer, gastrointestinal cancers and other cancers: a comparison of treatment with pantoprazole and other proton pump inhibitors

Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology

(2015) L. Lundell et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies

(2015) S. E. Attwood et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Pharmacokinetic Drug Interaction Profiles of Proton Pump Inhibitors: An Update

(2014) Ralph-Steven Wedemeyer et al.   DRUG SAFETY

Ulcer, gastric surgery and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case–Control Consortium (PanC4)

(2013) C. Bosetti et al.   ANNALS OF ONCOLOGY

Platelet Inhibitory Effect of Clopidogrel in Patients Treated With Omeprazole, Pantoprazole, and Famotidine: A Prospective, Randomized, Crossover Study

(2013) Yaron Arbel et al.   CLINICAL CARDIOLOGY

Acid suppressive drugs and gastric cancer: A meta-analysis of observational studies

(2013) Jeong Soo Ahn   WORLD JOURNAL OF GASTROENTEROLOGY

Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma

(2012) Hashem B. El-Serag   GASTROENTEROLOGY

Proton pump inhibitors and histamine-2-receptor antagonists and pancreatic cancer risk: a nested case–control study

(2011) M C Bradley et al.   BRITISH JOURNAL OF CANCER

Antiplatelet drug interactions

(2010) I. S. Mackenzie et al.   JOURNAL OF INTERNAL MEDICINE

Proton pump inhibitors and risk of gastric cancer: a population-based cohort study

(2009) A H Poulsen et al.   BRITISH JOURNAL OF CANCER

Colorectal cancer risk in relation to use of acid suppressive medications

(2009) Jessica Chubak et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Proton Pump Inhibitors and the Risk of Colorectal Cancer

(2008) Eva M. van Soest et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY